Anil Vachani - Faculty Biosketch

Anil Vachani, MD, MSCE

Emeritus Professor CE of Medicine (Pulmonary, Allergy and Critical Care)

Attending Physician, Philadelphia Veterans Administration Medical Center

Director of Clinical Research, Section of Interventional Pulmonology and Thoracic Oncology, Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine

Director of Bronchoscopy, Philadelphia Veterans Administration Medical Center

Co-Director Lung Cancer Screening Program, Perelman School of Medicine, University of Pennslvania

Co-Director, Lung Cancer Screening Program, Philadelphia Veterans Administration Medical Center

3 5f

Department: Medicine

4 1 b

46 Contact information
5c

Pulmonary, Allergy, and Critical Care Division
3e University of Pennsylvania Perelman School of Medicine
20 Suite 216, Stemmler Hall
35 3450 Hamilton Walk
Philadelphia, PA 19104

2e Office: 215.573.7931
30

Email:
avachani@pennmedicine.upenn.edu

4 3 3 3 2 4 b 1f

13 Education:
21 9 B.S. 15 (Genetics) c
3b University of California, Berkeley, 1992.
21 9 B.A. 16 (Economics) c
3b University of California, Berkeley, 1992.
21 9 M.D. 15 (Medicine) c
40 University of California, San Francisco, 1996.
21 9 MSCE 22 (Clinical Epidemiology) c
50 University of Pennsylvania, Perelman School of Medicine, 2013.
c

3 3 21

1f Post-Graduate Training
24 78 Categorical Internal Medicine Residency Program, Hospital of the University of Pennsylvania, Department of Medicine 1b , 1996-1999.
24 92 Fellowship, Pulmonary and Critical Care Medicine, Hospital of the University of Pennsylvania, Department of Medicine, 2000-2004.
c

3 25

17 Certifications
28 31 Internal Medicine (ABIM), 1999.
28 32 Pulmonary Medicine (ABIM), 2004.
28 36 Critical Care Medicine (ABIM), 2005.
28 32 Pulmonary Medicine (ABIM), 2014.
28 36 Critical Care Medicine (ABIM), 2015.
c

3 90 Permanent link
2 29

b6 > Perelman School of Medicine > Faculty > Details a

1e 1d

2b 29

Selected Publications

f2 Caruso CR, Kim RY, Rendle KA, Vachani A.: Evaluating the Non-Malignancy Rate in the National Lung Screening Trial: Addressing Surgical Misclassification. Chest May 2025.

f2 Dako F, Karasek P, Seward J, White K, Vachani A, Rendle K, Guerra C.: Measuring Health-Related Social Risks in a Lung Cancer Screening Cohort. J Am Coll Radiol Apr 2025.

132 Carroll NM, Eisenstein J, Wain KF, Freml JM, Greenlee RT, Honda SA, Neslund-Dudas C, Rendle KA, Vachani A, Ritzwoller DP.: Patterns of recurrence among adults diagnosed with screen-detected lung cancer. Cancer Epidemiol 95, Apr 2025.

19f Elston Lafata J, Rendle KA, Wainwright JV, Cooley ME, Vachani A, Neslund-Dudas C, Odelberg MR, Alcaro L, Staresinic C, Alexander GL, Carlson RB, Schapira MM.: Characterizing the Design of and Emerging Evidence for Health Care Organization-Based Lung Cancer Screening Interventions: A Systematic Review. MDM Policy Pract 10(1): 1-35, Apr 2025.

13d Kim RY, Rendle KA, Mitra N, Neslund-Dudas C, Greenlee RT, Honda SA, Schapira MM, Simoff MJ, Jeon J, Meza R, Ritzwoller DP, Vachani A.: Adherence to Annual Lung Cancer Screening and Rates of Cancer Diagnosis. JAMA Netw Open 8: e250942, Mar 2025.

165 Carroll NM, Eisenstein J, Freml JM, Burnett-Hartman AN, Greenlee RT, Honda SA, Neslund-Dudas CM, Rendle KA, Vachani A, Ritzwoller DP.: Association of systemic therapy with survival among adults with advanced non-small cell lung cancer. Transl Lung Cancer Res 14(1): 176-193, Jan 2025.

1d8 Rendle K.A., Saia C.A., Vachani A., Burnett-Hartman A.N., Doria-Rose V.P., Beucker S., Neslund-Dudas C., Oshiro C., Kim R.Y., Elston-Lafata J., Honda S.A., Ritzwoller D., Wainwright J.V., Mitra N., Greenlee R.T.: Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice: A Retrospective Cohort Study. Ann Intern Med 177(1): 18-28, Jan 2024

14a Ost DE, Maldonado F, Shafrin J, Kim J, Marin MA, Amos TB, Hertz DS, Kalsekar I, Vachani A.: Economic Value of Bronchoscopy Technologies that Improves Sensitivity for Malignancy for Peripheral Pulmonary Lesions. Ann Am Thorac Soc 21(12): 1759-1769, Dec 2024.

28e Mazzone PJ, Bach PB, Carey J, Schonewolf CA, Bognar K, Ahluwalia MS, Cruz-Correa M, Gierada D, Kotagiri S, Lloyd K, Maldonado F, Ortendahl JD, Sequist LV, Silvestri GA, Tanner N, Thompson JC, Vachani A, Wong KK, Zaidi AH, Catallini J, Gershman A, Lumbard K, Millberg LK, Nawrocki J, Portwood C, Rangnekar A, Sheridan CC, Trivedi N, Wu T, Zong Y, Cotton L, Ryan A, Cisar C, Leal A, Dracopoli NC, Scharpf RB, Velculescu VE, Pike LRG.: Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection. Cancer Discov 14(11): 2224-2242, Nov 2024.

1df Wainwright JV, Aggarwal C, Beucker S, Dougherty DW, Gabriel PE, Jacobs LA, Kalman J, Linn KA, Martella AO, Mehta SJ, Rhodes CM, Roy M, Schapira MM, Shulman LN, Steltz J, Stephens Shields AJ, Tan ASL, Thompson JC, Toneff H, Wender RC, Zeb S, Rendle KA, Vachani A, Bekelman JE; Penn TRACE.: University of Pennsylvania Telehealth Research Center of Excellence. J Natl Cancer Inst Monogr 2024: 62-69, Jun 2024.

2c

7 1d

2c back to top
26 Last updated: 05/22/2025
34 The Trustees of the University of Pennsylvania c